Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara L Weber

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Cancer Cell|June 28, 2002
Cancer genomicsBarbara L Weber
The Journal of Clinical Investigation|June 6, 2007
In the palace of the sultan: 2007 American Society for Clinical Investigation Presidential AddressBarbara L Weber
The New England Journal of Medicine|June 6, 2003
Breast and ovarian cancerRichard Wooster, Barbara L Weber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Genetic variants of uncertain significance: flies in the ointmentSusan Domchek, Barbara L Weber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Risk management in BRCA1 and BRCA2 mutation carriers: lessons learned, challenges posedAngela DeMichele, Barbara L Weber
Current Opinion in Oncology|November 1, 2002
Recent advances in breast cancer biologySusan M Domchek, Barbara L Weber
American Journal of Human Genetics|April 24, 2003
Resolving ATM haplotypes in whitesRichard Letrero, Barbara L Weber, Katherine L Nathanson
Cancer Cell|September 6, 2003
BRAF as a potential therapeutic target in melanoma and other malignanciesDavid A Tuveson, Barbara L Weber, Meenhard Herlyn
Nature Clinical Practice. Oncology|January 13, 2006
Clinical management of BRCA1 and BRCA2 mutation carriersSusan M Domchek, Katrina Armstrong, Barbara L Weber
Clinical and Translational Science|October 13, 2020
Optimizing the Therapeutic Window of Targeted Drugs in Oncology: Potency-Guided First-in-Human StudiesMatthew J Goldstein, Malte Peters, Barbara L Weber, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Cancer Cell|June 28, 2002
Cancer genomicsBarbara L Weber
The Journal of Clinical Investigation|June 6, 2007
In the palace of the sultan: 2007 American Society for Clinical Investigation Presidential AddressBarbara L Weber
The New England Journal of Medicine|June 6, 2003
Breast and ovarian cancerRichard Wooster, Barbara L Weber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Genetic variants of uncertain significance: flies in the ointmentSusan Domchek, Barbara L Weber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Risk management in BRCA1 and BRCA2 mutation carriers: lessons learned, challenges posedAngela DeMichele, Barbara L Weber
Current Opinion in Oncology|November 1, 2002
Recent advances in breast cancer biologySusan M Domchek, Barbara L Weber
American Journal of Human Genetics|April 24, 2003
Resolving ATM haplotypes in whitesRichard Letrero, Barbara L Weber, Katherine L Nathanson
Cancer Cell|September 6, 2003
BRAF as a potential therapeutic target in melanoma and other malignanciesDavid A Tuveson, Barbara L Weber, Meenhard Herlyn
Nature Clinical Practice. Oncology|January 13, 2006
Clinical management of BRCA1 and BRCA2 mutation carriersSusan M Domchek, Katrina Armstrong, Barbara L Weber
Clinical and Translational Science|October 13, 2020
Optimizing the Therapeutic Window of Targeted Drugs in Oncology: Potency-Guided First-in-Human StudiesMatthew J Goldstein, Malte Peters, Barbara L Weber, et al.
Pageof 9